When comparing patients who initiated treatment with exenatide (n=14,076, median follow-up: 969 days), to those starting dulaglutide (n=54,787, median follow-up: 948 days) or liraglutide (n=25,562, median follow-up: 1,007 days), no differences were found in the hazard of composite treatment for diabetic macular edema (DME) and/or proliferative DR: exenatide vs
Most of the time, the types of weight loss that people experience when the scale goes down is a combination of fat mass AND muscle mass
Comparing Semaglutide vs Tirzepatide vs Lipotropic Injections (Lipo-C): What is the Verdict
Can Glutathione Injections Be Combined with Other Treatments
Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells